Shenzhen Mindray Stock Hits Day Low Amid Price Pressure, Closing at CNY 152.90

Shenzhen Mindray Bio-Medical Electronics Co., Ltd. experienced a notable decline today, with the stock dropping by 3.32% on May 22, 2026. The stock reached an intraday low of CNY 152.90, reflecting ongoing challenges in its performance metrics. Over the past week, the stock has decreased by 4.6%, and its one-month performance shows a decline of 4.14%. In the longer term, Shenzhen Mindray has faced significant hurdles, with a year-to-date performance of -19.66% and a staggering -51.12% over the past three years. The company has reported negative results for the last seven consecutive quarters, with net profit for the first nine months showing a decline of 19.91%. Despite these challenges, the company maintains a return on equity of 22.52% and a dividend yield of 2.89%. However, its valuation appears high with a price-to-book ratio of 5.51. As a large-cap player in the Pharmaceuticals & Biotechnology industry, Shenzhen Mindray's performance continues to lag behind the China Shanghai Composite index across various time frames.